California State Teachers Retirement System Selecta Biosciences Inc Transaction History

California State Teachers Retirement System

$84.1 Billion
Q3 2024

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$0.62 - $0.85 $8,212 - $11,259	-13,246 Reduced 68.5%	6,092 $5,000
Q4 2023 Feb 13, 2024	SELL	$0.67 - $1.35 $4,213 - $8,490	-6,289 Reduced 24.54%	19,338 $13,000
Q3 2023 Nov 14, 2023	SELL	$1.02 - $1.23 $13,268 - $15,999	-13,008 Reduced 33.67%	25,627 $27,000
Q2 2023 Aug 21, 2023	BUY	$1.04 - $1.4 $40,180 - $54,089	38,635 New	38,635 $43,000
Q2 2022 Aug 15, 2022	SELL	$0.67 - $1.4 $26,286 - $54,927	-39,234 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$1.23 - $3.31 $13,752 - $37,009	-11,181 Reduced 22.18%	39,234 $48,000
Q3 2021 Nov 15, 2021	SELL	$3.36 - $4.62 $244,658 - $336,405	-72,815 Reduced 59.09%	50,415 $210,000
Q2 2021 Aug 16, 2021	BUY	$2.82 - $5.01 $59,180 - $105,139	20,986 Added 20.53%	123,230 $515,000
Q2 2020 Aug 17, 2020	BUY	$1.83 - $4.06 $187,106 - $415,110	102,244 New	102,244 $290,000
Q2 2019 Aug 14, 2019	SELL	$1.79 - $3.05 $94,864 - $161,640	-52,997 Closed	0 $0
Q1 2019 May 09, 2019	BUY	$1.47 - $3.06 $34,836 - $72,515	23,698 Added 80.88%	52,997 $126,000
Q4 2018 Feb 13, 2019	BUY	$2.66 - $15.93 $4,649 - $27,845	1,748 Added 6.34%	29,299 $78,000
Q2 2018 Aug 14, 2018	BUY	$9.36 - $13.25 $56,487 - $79,963	6,035 Added 28.05%	27,551 $365,000
Q1 2018 May 15, 2018	SELL	$8.49 - $11.82 $4,958 - $6,902	-584 Reduced 2.64%	21,516 $219,000
Q4 2017 Feb 14, 2018	SELL	$8.97 - $23.38 $4,485 - $11,690	-500 Reduced 2.21%	22,100 $217,000
Q3 2017 Nov 13, 2017	BUY	$15.22 - $20.03 $343,972 - $452,678	22,600	22,600 $412,000

Others Institutions Holding SELB

# of Institutions

Shares Held

4.67M

Call Options Held

Put Options Held

View Full List

About SELECTA BIOSCIENCES INC

Ticker SELB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 152,712,992
Market Cap $128M
Description
Selecta Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the research and development of nanoparticle immunomodulatory drugs for the treatment and prevention of human diseases. The company's lead therapeutic gene therapy program is SEL-302 that is in preclinical stage to improve the treatment of methylmalonic acidemia. I...

More about SELB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of California State Teachers Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California State Teachers Retirement System with notifications on news.

Account